<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d685f-63a9-7d2c-828a-6545319712d9,g:ea22fc1e-238b-4dee-9c31-51961c17795a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="oncy-20260331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019d7645-e4ba-7faf-a3ed-beb83ef70a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d7645-e4ba-76c3-8f8b-32c6716a760b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d7645-e4ba-7faf-a3ed-beb83ef70a5f" xlink:to="loc_us-gaap_AssetsCurrent_019d7645-e4ba-76c3-8f8b-32c6716a760b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d7645-e4ba-7e53-9e4b-139ffced8825" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d7645-e4ba-7faf-a3ed-beb83ef70a5f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d7645-e4ba-7e53-9e4b-139ffced8825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d7645-e4ba-74f4-90c3-3932ab40457c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d7645-e4ba-7faf-a3ed-beb83ef70a5f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d7645-e4ba-74f4-90c3-3932ab40457c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d7645-e4ba-78ef-bd37-15fc27a56315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d7645-e4ba-77cd-9eb7-8b4e19ede63d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d7645-e4ba-78ef-bd37-15fc27a56315" xlink:to="loc_us-gaap_LiabilitiesCurrent_019d7645-e4ba-77cd-9eb7-8b4e19ede63d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019d7645-e4ba-762f-aa51-deba2a473707" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d7645-e4ba-78ef-bd37-15fc27a56315" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019d7645-e4ba-762f-aa51-deba2a473707" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019d7645-e4ba-7582-b1bc-38cea7fd1f22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d7645-e4ba-78ef-bd37-15fc27a56315" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019d7645-e4ba-7582-b1bc-38cea7fd1f22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_019df146-5ab8-7045-983c-92c5f5d3fdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d7645-e4ba-78ef-bd37-15fc27a56315" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_019df146-5ab8-7045-983c-92c5f5d3fdcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d7645-e4ba-725a-96b4-1d0a2de02085" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d7645-e4ba-7fb4-9cda-1f9a7b9503a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d7645-e4ba-725a-96b4-1d0a2de02085" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d7645-e4ba-7fb4-9cda-1f9a7b9503a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_019d7645-e4ba-73a2-a745-cfc7aa82ad1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d7645-e4ba-725a-96b4-1d0a2de02085" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_019d7645-e4ba-73a2-a745-cfc7aa82ad1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019d7645-e4ba-7465-a8c4-8b70ed0a8168" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d7645-e4ba-725a-96b4-1d0a2de02085" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_019d7645-e4ba-7465-a8c4-8b70ed0a8168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d7645-e4ba-756e-8d43-e9948a0e1180" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019d7645-e4ba-7847-ae0a-7c2b3eb3bf16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d7645-e4ba-756e-8d43-e9948a0e1180" xlink:to="loc_us-gaap_AccountsPayableCurrent_019d7645-e4ba-7847-ae0a-7c2b3eb3bf16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d7645-e4ba-7237-b63a-3e59918f0e29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d7645-e4ba-756e-8d43-e9948a0e1180" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019d7645-e4ba-7237-b63a-3e59918f0e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019d7645-e4ba-7727-8393-08310bfaad41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d7645-e4ba-756e-8d43-e9948a0e1180" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019d7645-e4ba-7727-8393-08310bfaad41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_019d7645-e4ba-7ce8-b8c1-ae456387e52f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d7645-e4ba-756e-8d43-e9948a0e1180" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_019d7645-e4ba-7ce8-b8c1-ae456387e52f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d7645-e4ba-7b64-b115-97df65fb5680" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d7645-e4ba-7f55-9fe0-5c37987cd92e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d7645-e4ba-7b64-b115-97df65fb5680" xlink:to="loc_us-gaap_Liabilities_019d7645-e4ba-7f55-9fe0-5c37987cd92e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019d7645-e4ba-720d-8097-2fc0e15a972c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d7645-e4ba-7b64-b115-97df65fb5680" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019d7645-e4ba-720d-8097-2fc0e15a972c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d7645-e4ba-7b00-81f8-1860207a67f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d7645-e4ba-7b64-b115-97df65fb5680" xlink:to="loc_us-gaap_StockholdersEquity_019d7645-e4ba-7b00-81f8-1860207a67f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d7645-e4ba-7873-9936-2817a2b91133" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019d7645-e4ba-75bd-86b6-ab2b55b50c09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d7645-e4ba-7873-9936-2817a2b91133" xlink:to="loc_us-gaap_CommonStockValue_019d7645-e4ba-75bd-86b6-ab2b55b50c09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019d7645-e4ba-710a-90f8-969d58b69ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d7645-e4ba-7873-9936-2817a2b91133" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019d7645-e4ba-710a-90f8-969d58b69ef7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019d7645-e4ba-704c-858f-41142aed4822" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d7645-e4ba-7873-9936-2817a2b91133" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019d7645-e4ba-704c-858f-41142aed4822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d7645-e4ba-7db4-bada-ac724cb6e837" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d7645-e4ba-7873-9936-2817a2b91133" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d7645-e4ba-7db4-bada-ac724cb6e837" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSunaudited" xlink:type="simple" xlink:href="oncy-20260331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSunaudited"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d8661-bd0b-7172-a7a2-362388a02176" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d8661-bd0b-78c6-a5a4-e7f330313ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d8661-bd0b-7172-a7a2-362388a02176" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d8661-bd0b-78c6-a5a4-e7f330313ea5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d8661-bd0b-7d6f-8545-850f5a884d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d8661-bd0b-7172-a7a2-362388a02176" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d8661-bd0b-7d6f-8545-850f5a884d9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d8661-bd0b-7b31-b0d5-b4165d324680" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d8661-bd0b-7818-992f-122410e202e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d8661-bd0b-7b31-b0d5-b4165d324680" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d8661-bd0b-7818-992f-122410e202e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d8661-bd0b-7fc2-a288-69518df90704" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d8661-bd0b-7b31-b0d5-b4165d324680" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d8661-bd0b-7fc2-a288-69518df90704" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d8661-bd0c-7d9e-b687-3e55211458a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d8661-bd0c-774e-bd2c-97312ebeee26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d8661-bd0c-7d9e-b687-3e55211458a0" xlink:to="loc_us-gaap_NetIncomeLoss_019d8661-bd0c-774e-bd2c-97312ebeee26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019d8661-bd0c-7f03-85a3-d7ecda4a5a54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d8661-bd0c-7d9e-b687-3e55211458a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019d8661-bd0c-7f03-85a3-d7ecda4a5a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d8661-bd0b-756e-aec3-a5e2bcd96e60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019d8661-bd0b-7099-9a18-c6b21f685452" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019d8661-bd0b-756e-aec3-a5e2bcd96e60" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019d8661-bd0b-7099-9a18-c6b21f685452" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_019d8661-bd0b-7097-b48b-005a601fc77a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019d8661-bd0b-756e-aec3-a5e2bcd96e60" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_019d8661-bd0b-7097-b48b-005a601fc77a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019d8661-bd0b-7e7a-9366-718eb26f8561" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019d8661-bd0b-756e-aec3-a5e2bcd96e60" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019d8661-bd0b-7e7a-9366-718eb26f8561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d8661-bd0b-7f20-bcee-ea373d37f08b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d8661-bd0b-752a-9ab5-cb1e720782e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d8661-bd0b-7f20-bcee-ea373d37f08b" xlink:to="loc_us-gaap_OperatingExpenses_019d8661-bd0b-752a-9ab5-cb1e720782e2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="simple" xlink:href="oncy-20260331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d86bc-009c-7b9a-9ee1-31b95b521695" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d86bc-009c-7d1a-805e-5a88be257c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d86bc-009c-7b9a-9ee1-31b95b521695" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d86bc-009c-7d1a-805e-5a88be257c5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d86bc-009c-78d4-bc74-0d98f42eff8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d86bc-009c-74a1-bb42-09bce979b2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d86bc-009c-78d4-bc74-0d98f42eff8b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d86bc-009c-74a1-bb42-09bce979b2b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d86bc-009c-71ec-afec-2a22cf466b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_NetIncomeLoss_019d86bc-009c-71ec-afec-2a22cf466b6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019d86bc-009c-79ef-a952-e49fcad99f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_Depreciation_019d86bc-009c-79ef-a952-e49fcad99f4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_NoncashLeaseExpense_019d86bc-009c-7ecf-8261-66d8537a18fa" xlink:href="oncy-20260331.xsd#oncy_NoncashLeaseExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_oncy_NoncashLeaseExpense_019d86bc-009c-7ecf-8261-66d8537a18fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019d86bc-009c-76cc-80a1-7b0ce4c3ed68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_ShareBasedCompensation_019d86bc-009c-76cc-80a1-7b0ce4c3ed68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019d86bc-009c-721f-96da-2431410863e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019d86bc-009c-721f-96da-2431410863e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_019d86bc-009c-7d22-8905-907e3cf323b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_019d86bc-009c-7d22-8905-907e3cf323b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019d86bc-009c-73fb-b806-e6438eaf0f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019d86bc-009c-73fb-b806-e6438eaf0f7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_019d86bc-009c-73ee-b76a-457c07edbed2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_019d86bc-009c-73ee-b76a-457c07edbed2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_019d86bc-009c-7825-9cdb-e35f38cdb4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_019d86bc-009c-7825-9cdb-e35f38cdb4e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d86bc-009c-7d97-80e2-3c6039bf6b99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d86bc-009c-7d97-80e2-3c6039bf6b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019d86bc-009c-7672-a587-93c7210f18c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019d86bc-009c-7672-a587-93c7210f18c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019d86bc-009c-7221-9e1d-fd7f5a5a5e05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7d3c-bb3b-f709f39193db" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019d86bc-009c-7221-9e1d-fd7f5a5a5e05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d86bc-009c-7db8-bb88-f18b0b9e2129" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7427-a826-5350fefee45e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d86bc-009c-7db8-bb88-f18b0b9e2129" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d86bc-009c-7427-a826-5350fefee45e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d86bc-009c-79fe-b116-aa0aaee0a773" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d86bc-009c-7db8-bb88-f18b0b9e2129" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d86bc-009c-79fe-b116-aa0aaee0a773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d86bc-009c-74b9-bf23-b8e2a55ba368" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d86bc-009c-7db8-bb88-f18b0b9e2129" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d86bc-009c-74b9-bf23-b8e2a55ba368" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d86bc-009c-7e38-92ca-47e67485ab38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d86bc-009c-7db8-bb88-f18b0b9e2129" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d86bc-009c-7e38-92ca-47e67485ab38" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesDetails" xlink:type="simple" xlink:href="oncy-20260331.xsd#BalanceSheetDetailsScheduleofPrepaidExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019d86c8-00f2-7128-b0f2-3d095a8ddbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_PrepaidResearchAndDevelopment_019d86c8-00f2-7af1-9a9e-6b08d59efa74" xlink:href="oncy-20260331.xsd#oncy_PrepaidResearchAndDevelopment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019d86c8-00f2-7128-b0f2-3d095a8ddbb2" xlink:to="loc_oncy_PrepaidResearchAndDevelopment_019d86c8-00f2-7af1-9a9e-6b08d59efa74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_019d86c8-00f2-79a6-9218-d8f7e096820e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019d86c8-00f2-7128-b0f2-3d095a8ddbb2" xlink:to="loc_us-gaap_PrepaidInsurance_019d86c8-00f2-79a6-9218-d8f7e096820e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_PrepaidProfessionalFees_019d86c8-00f2-7e46-9ee8-83d18c7bd5a8" xlink:href="oncy-20260331.xsd#oncy_PrepaidProfessionalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019d86c8-00f2-7128-b0f2-3d095a8ddbb2" xlink:to="loc_oncy_PrepaidProfessionalFees_019d86c8-00f2-7e46-9ee8-83d18c7bd5a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_019d86c8-00f2-7113-bfe6-fca1cee3809c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019d86c8-00f2-7128-b0f2-3d095a8ddbb2" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_019d86c8-00f2-7113-bfe6-fca1cee3809c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/BalanceSheetDetailsScheduleofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="oncy-20260331.xsd#BalanceSheetDetailsScheduleofAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/BalanceSheetDetailsScheduleofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d86c8-00f2-7a8b-81ac-40e05e91bc02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_AccruedResearchAndDevelopmentCurrent_019d86c8-00f2-7439-980f-ba7ed4444059" xlink:href="oncy-20260331.xsd#oncy_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d86c8-00f2-7a8b-81ac-40e05e91bc02" xlink:to="loc_oncy_AccruedResearchAndDevelopmentCurrent_019d86c8-00f2-7439-980f-ba7ed4444059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019d86c8-00f2-760d-8a09-24d06d26c979" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d86c8-00f2-7a8b-81ac-40e05e91bc02" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019d86c8-00f2-760d-8a09-24d06d26c979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d86c8-00f2-789d-acda-51dcf725a890" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d86c8-00f2-7a8b-81ac-40e05e91bc02" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d86c8-00f2-789d-acda-51dcf725a890" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="oncy-20260331.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d86cc-5b1e-7f07-8ce2-6cc760b0303b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019d86cc-5b1e-78ae-8a0a-f83394f57215" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d86cc-5b1e-7f07-8ce2-6cc760b0303b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019d86cc-5b1e-78ae-8a0a-f83394f57215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019d86cc-5b1e-77ec-87e1-d5e4f27d37b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d86cc-5b1e-7f07-8ce2-6cc760b0303b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019d86cc-5b1e-77ec-87e1-d5e4f27d37b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019d86cc-5b1e-7251-8bee-998cfbac013c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d86cc-5b1e-7f07-8ce2-6cc760b0303b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019d86cc-5b1e-7251-8bee-998cfbac013c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019d86cc-5b1e-7f3d-8e36-724651e1f207" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d86cc-5b1e-7f07-8ce2-6cc760b0303b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019d86cc-5b1e-7f3d-8e36-724651e1f207" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="oncy-20260331.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d86cc-5b1e-72b8-8e4d-9dfb06be768a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019d86cc-5b1e-7c56-975e-23803edbc5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d86cc-5b1e-72b8-8e4d-9dfb06be768a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019d86cc-5b1e-7c56-975e-23803edbc5e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019d86cc-5b1e-74bd-9cb2-27817b9c5e84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d86cc-5b1e-72b8-8e4d-9dfb06be768a" xlink:to="loc_us-gaap_OperatingLeaseLiability_019d86cc-5b1e-74bd-9cb2-27817b9c5e84" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/SegmentInformationScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="oncy-20260331.xsd#SegmentInformationScheduleofSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/SegmentInformationScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d869c-37fe-75d4-b688-733fa39fd4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_ResearchAndDevelopmentExpenseClinicalTrial_019d869c-37fe-7d06-8efd-294ff16c07bf" xlink:href="oncy-20260331.xsd#oncy_ResearchAndDevelopmentExpenseClinicalTrial"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d869c-37fe-75d4-b688-733fa39fd4fa" xlink:to="loc_oncy_ResearchAndDevelopmentExpenseClinicalTrial_019d869c-37fe-7d06-8efd-294ff16c07bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_ResearchAndDevelopmentExpenseManufacturingAndRelatedProcessDevelopment_019d869c-37fe-7f93-a2fa-b3abb45c9a9d" xlink:href="oncy-20260331.xsd#oncy_ResearchAndDevelopmentExpenseManufacturingAndRelatedProcessDevelopment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d869c-37fe-75d4-b688-733fa39fd4fa" xlink:to="loc_oncy_ResearchAndDevelopmentExpenseManufacturingAndRelatedProcessDevelopment_019d869c-37fe-7f93-a2fa-b3abb45c9a9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019d869c-37fe-7887-82ed-e1ff6ddddf77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d869c-37fe-75d4-b688-733fa39fd4fa" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019d869c-37fe-7887-82ed-e1ff6ddddf77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_019d869c-37fe-7fe4-b261-2318ebbebaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d869c-37fe-75d4-b688-733fa39fd4fa" xlink:to="loc_us-gaap_ProfessionalFees_019d869c-37fe-7fe4-b261-2318ebbebaf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalariesWagesAndOfficersCompensation_019d869c-37fe-7313-82b5-e90aac03478e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalariesWagesAndOfficersCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d869c-37fe-75d4-b688-733fa39fd4fa" xlink:to="loc_us-gaap_SalariesWagesAndOfficersCompensation_019d869c-37fe-7313-82b5-e90aac03478e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_IntellectualPropertyExpense_019d869c-37fe-7569-8ce5-f34a86f63d7d" xlink:href="oncy-20260331.xsd#oncy_IntellectualPropertyExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d869c-37fe-75d4-b688-733fa39fd4fa" xlink:to="loc_oncy_IntellectualPropertyExpense_019d869c-37fe-7569-8ce5-f34a86f63d7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_OtherResearchAndDevelopmentExpenseAndOtherGeneralAndAdministrativeExpense_019d869c-37fe-714c-a939-b6fa7690fdf6" xlink:href="oncy-20260331.xsd#oncy_OtherResearchAndDevelopmentExpenseAndOtherGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d869c-37fe-75d4-b688-733fa39fd4fa" xlink:to="loc_oncy_OtherResearchAndDevelopmentExpenseAndOtherGeneralAndAdministrativeExpense_019d869c-37fe-714c-a939-b6fa7690fdf6" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
